Cognitive dysfunction in patients with small-cell lung cancer: Incidence, causes, and suggestions on management

Anne Kanard, Stephen Frytak, Aminah Jatoi

Research output: Contribution to journalReview article

20 Scopus citations

Abstract

Cognitive dysfunction is a common occurrence among patients with small-cell lung cancer, with prevalence rates ranging anywhere from 15% to 90%. Although prophylactic cranial irradiation has been described as one culprit to explain these cognitive deficits, other causes also have been implicated. This review provides a summary of the factors that may contribute to cognitive decline in this group of patients and comments upon how cognitive dysfunction or the risk for it might influence patient management.

Original languageEnglish (US)
Pages (from-to)127-132
Number of pages6
JournalJournal of Supportive Oncology
Volume2
Issue number2
StatePublished - Mar 1 2004

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Cognitive dysfunction in patients with small-cell lung cancer: Incidence, causes, and suggestions on management'. Together they form a unique fingerprint.

  • Cite this